Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of ASC40 (Denifanstat) Tablets in the Treatment of Patients With Moderate to Severe Acne Vulgaris [Phase 3]

View source ↗

Summary

The update notes the completion of a Phase 3 trial evaluating ASC40 (Denifanstat) tablets for moderate to severe acne vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• ASC40 (Denifanstat) (Denifanstat)

Snippet

Sponsor: Ascletis Pharmaceuticals Co., Ltd. | Conditions: Acne | Phase 3 | Status: COMPLETED